Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study
- PMID: 1683686
- DOI: 10.1007/BF00182999
Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study
Abstract
The partial dopamine receptor agonists SDZ 208-911 (N-[(8-alpha)-2,6-dimethylergoline-8-yl]-2,2-dimethylpropanamid e), SDZ 208-912 (N-[8-alpha)-2-chloro-6-methylergoline-8-yl]-2,2- dimethylpropanamide) and terguride (transdihydrolisuride; TDHL) were tested in biochemical, behavioral (locomotor activity) and electrophysiological assays in male rats. In reserpine-pretreated rats, SDZ 208-911 and terguride dose-dependently reduced striatal DOPA formation (NSD 1015 treatment) with similar efficacy (-80%) and potency as the selective D2 receptor agonist quinpirole (LY 171555). SDZ 208-912 only produced a partial reduction (-32%) at the highest dose tested. SDZ 208-911 and terguride partially reversed (by approximately 50%) the gamma-butyrolactone (GBL)-induced increase in striatal DOPA accumulation. Quinpirole produced a 100% reversal while SDZ208-912, per se, was inactive. While quinpirole decreased DOPA accumulation, all three partial agonists elevated striatal DOPA accumulation in non-pretreated rats with SDZ 208-912 being as potent and efficacious as haloperidol. The three partial agonists displayed comparatively high affinities in vitro for the dopamine D2 (3H-spiperone) receptor site and somewhat lower affinity for the 5-HT1A (3H-8-OH-DPAT) receptor site. SDZ 208-911 and SDZ 208-912 also showed high affinities for central alpha 2 (3H-idazoxane) receptors. In line with these findings, the partial ergoline agonists dose-dependently elevated the DOPA accumulation in the noradrenaline-rich cortical brain region and decreased the 5-HT synthesis rate (5-HTP accumulation) in the limbic brain region. Furthermore, high doses of SDZ 208-911 and terguride produced weak signs of the 5-HT behavioral syndrome (flat body posture) in reserpinized rats. In the locomotor activity studies in non-pretreated rats, SDZ 208-911, SDZ 208-912 and terguride reduced the activity to 10-20% of controls with SDZ 208-912 being approximately ten times less potent than the other two compounds. Weak postsynaptic dopamine receptor agonist effects of the partial agonists were demonstrated only in reserpine-pretreated rats; all three partial agonists tested produced occasional forward locomotion and the so-called "jerking" behavior. Extracellular single unit recordings were carried out in chloral hydrate-anesthetized rats to investigate the effects on firing rates of dopamine neurons located in the substantia nigra pars compacta. Intravenous administration of SDZ 208-911 and terguride depressed the firing rate by 42 and 53%, respectively, while apomorphine completely inhibited the cells. SDZ 208-912 only reduced the firing by 16% and some cells displayed a biphasic response with a weak depression at low doses that disappeared at high doses.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Quinpirole--a 5-HT receptor antagonist?Neurosci Lett. 1991 May 13;126(1):57-9. doi: 10.1016/0304-3940(91)90370-9. Neurosci Lett. 1991. PMID: 1678151
-
Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.Brain Res. 2006 Feb 16;1073-1074:269-75. doi: 10.1016/j.brainres.2005.12.054. Epub 2006 Jan 19. Brain Res. 2006. PMID: 16427034
-
Electrophysiological evaluation of a partial agonist of dopamine receptors.J Pharmacol Exp Ther. 1987 Oct;243(1):391-6. J Pharmacol Exp Ther. 1987. PMID: 3668865
-
Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists.Eur J Pharmacol. 1986 Apr 16;123(2):237-51. doi: 10.1016/0014-2999(86)90665-5. Eur J Pharmacol. 1986. PMID: 2940101 Review.
-
Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence.J Neural Transm. 1985;62(1-2):1-52. doi: 10.1007/BF01260414. J Neural Transm. 1985. PMID: 3894582 Review.
Cited by
-
Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys.Psychopharmacology (Berl). 2003 Mar;166(3):298-305. doi: 10.1007/s00213-002-1347-0. Epub 2003 Feb 13. Psychopharmacology (Berl). 2003. PMID: 12589523
-
Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in Rats.PLoS One. 2015 Jul 10;10(7):e0132722. doi: 10.1371/journal.pone.0132722. eCollection 2015. PLoS One. 2015. PMID: 26162083 Free PMC article.
-
Development of pharmacotherapies for drug addiction: a Rosetta stone approach.Nat Rev Drug Discov. 2009 Jun;8(6):500-15. doi: 10.1038/nrd2828. Nat Rev Drug Discov. 2009. PMID: 19483710 Free PMC article. Review.
-
The partial dopamine D2-like receptor agonist terguride functions as an agonist in preweanling rats after a 5-day reserpine regimen.Psychopharmacology (Berl). 2006 Mar;185(1):104-11. doi: 10.1007/s00213-005-0263-5. Epub 2006 Jan 31. Psychopharmacology (Berl). 2006. PMID: 16447063
-
Effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on the prolactin suppression induced by a series of full and partial dopamine D2 receptor agonists in male rats.Naunyn Schmiedebergs Arch Pharmacol. 1992 Aug;346(2):152-7. doi: 10.1007/BF00165296. Naunyn Schmiedebergs Arch Pharmacol. 1992. PMID: 1360151
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous